Get started
AstraZeneca PLCAstraZeneca PLCAstraZeneca PLC

AstraZeneca PLC

No trades
OverviewFinancialsNewsCommunityTechnicalsForecastsSeasonalsOptionsBondsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪319.19 B‬ USD
Dividend yield (indicated)
1.62%
Price to earnings Ratio (TTM)
30.14
Basic EPS (TTM)
6.76 USD
Net income (FY)
‪10.45 B‬ USD
Revenue (FY)
‪60.05 B‬ USD
Shares float
‪1.48 B‬
Beta (1Y)
1.03

About AstraZeneca PLC


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Pascal Soriot
Website
astrazeneca.com
Headquarters
Cambridge
Founded
1913
IPO date
Sep 21, 2007
Identifiers
2
ISIN GB0009895292
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Check out other big names from the same industry as AZN.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


US46353AU2
AstraZeneca PLC 4.375% 17-AUG-2048
Yield to maturity
5.27%
Maturity date
Aug 17, 2048
US46353AM0
AstraZeneca PLC 4.375% 16-NOV-2045
Yield to maturity
5.27%
Maturity date
Nov 16, 2045
AZN5025310
AstraZeneca PLC 2.125% 06-AUG-2050
Yield to maturity
5.25%
Maturity date
Aug 6, 2050
AZN5193312
AstraZeneca PLC 3.0% 28-MAY-2051
Yield to maturity
5.23%
Maturity date
May 28, 2051
AZN3901525
AstraZeneca PLC 4.0% 18-SEP-2042
Yield to maturity
5.18%
Maturity date
Sep 18, 2042
AZN.GE
AstraZeneca PLC 6.45% 15-SEP-2037
Yield to maturity
4.78%
Maturity date
Sep 15, 2037
A
US4636NAN3
AstraZeneca Finance LLC 5.0% 26-FEB-2034
Yield to maturity
4.43%
Maturity date
Feb 26, 2034
A
AZN5549116
AstraZeneca Finance LLC 4.875% 03-MAR-2033
Yield to maturity
4.21%
Maturity date
Mar 3, 2033
50UC
AstraZeneca PLC 5.75% 13-NOV-2031
Yield to maturity
4.19%
Maturity date
Nov 13, 2031
A
US4636NAM5
AstraZeneca Finance LLC 4.9% 26-FEB-2031
Yield to maturity
4.12%
Maturity date
Feb 26, 2031
A
AZN5193314
AstraZeneca Finance LLC 2.25% 28-MAY-2031
Yield to maturity
4.02%
Maturity date
May 28, 2031

See all AZN bonds 

ETFs holding the stock


VXUS
Vanguard Total International Stock ETF
Weight
0.69%
Market value
‪4.05 B‬
USD
VEA
Vanguard FTSE Developed Markets ETF
Weight
0.96%
Market value
‪2.62 B‬
USD
IEFA
iShares Core MSCI EAFE ETF
Weight
1.23%
Market value
‪2.19 B‬
USD
ISFD
iShares PLC - iShares Core FTSE 100 UCITS ETF Accum Hedged USD
Weight
8.93%
Market value
‪1.79 B‬
USD
ISF
iShares Core FTSE 100 UCITS ETF GBP (Dist)
Weight
8.93%
Market value
‪1.79 B‬
USD
CEB4
iShares Core FTSE 100 UCITS ETF Accum Shs Hedged EUR
Weight
8.93%
Market value
‪1.79 B‬
USD
EFA
iShares MSCI EAFE ETF
Weight
1.44%
Market value
‪1.10 B‬
USD
VUKE
Vanguard FTSE 100 UCITS ETF
Weight
8.58%
Market value
‪729.87 M‬
USD
VUKG
Vanguard Funds PLC - Vanguard FTSE 100 UCITS ETF AccumGBP
Weight
8.58%
Market value
‪729.87 M‬
USD
VGK
Vanguard FTSEEuropean ETF
Weight
1.84%
Market value
‪686.59 M‬
USD
SCHF
Schwab International Equity ETF
Weight
1.07%
Market value
‪651.96 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of AZN is 205.55 USD — it has increased by 0.50% in the past 24 hours. Watch AstraZeneca PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange AstraZeneca PLC stocks are traded under the ticker AZN.
AZN stock has risen by 7.92% compared to the previous week, the month change is a 8.05% rise, over the last year AstraZeneca PLC has showed a 40.31% increase.
We've gathered analysts' opinions on AstraZeneca PLC future price: according to them, AZN price has a max estimate of 279.47 USD and a min estimate of 157.03 USD. Watch AZN chart and read a more detailed AstraZeneca PLC stock forecast: see what analysts think of AstraZeneca PLC and suggest that you do with its stocks.
AZN reached its all-time high on Jan 27, 2026 with the price of 195.00 USD, and its all-time low was 30.20 USD and was reached on Mar 5, 2009. View more price dynamics on AZN chart.
See other stocks reaching their highest and lowest prices.
AZN stock is 1.28% volatile and has beta coefficient of 1.03. Track AstraZeneca PLC stock price on the chart and check out the list of the most volatile stocks — is AstraZeneca PLC there?
Today AstraZeneca PLC has the market capitalization of ‪319.18 B‬, it has increased by 0.50% over the last week.
Yes, you can track AstraZeneca PLC financials in yearly and quarterly reports right on TradingView.
AstraZeneca PLC is going to release the next earnings report on Apr 29, 2026. Keep track of upcoming events with our Earnings Calendar.
AZN earnings for the last quarter are 2.12 USD per share, whereas the estimation was 2.09 USD resulting in a 1.45% surprise. The estimated earnings for the next quarter are 2.50 USD per share. See more details about AstraZeneca PLC earnings.
AstraZeneca PLC revenue for the last quarter amounts to ‪15.50 B‬ USD, despite the estimated figure of ‪15.44 B‬ USD. In the next quarter, revenue is expected to reach ‪14.69 B‬ USD.
AZN net income for the last quarter is ‪2.36 B‬ USD, while the quarter before that showed ‪2.52 B‬ USD of net income which accounts for −6.67% change. Track more AstraZeneca PLC financial stats to get the full picture.
AstraZeneca PLC dividend yield was 1.71% in 2025, and payout ratio reached 47.19%. The year before the numbers were 2.35% and 69.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AstraZeneca PLC EBITDA is ‪19.78 B‬ USD, and current EBITDA margin is 32.92%. See more stats in AstraZeneca PLC financial statements.
Like other stocks, AZN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AstraZeneca PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AstraZeneca PLC technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AstraZeneca PLC stock shows the strong buy signal. See more of AstraZeneca PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.